About Abiogenesis Clinpharm
Abiogenesis Clinpharm is a Healthcare company based in Hyderabad (India) founded in 2014 by Pawan Bhusari. It offers clinical trial services for drugs, vaccines, and medical devices in various therapeutic areas. It operates on a B2B and Service-Based Partnerships model. The company has 28 employees. Its chief executive, as recorded, is Pawan Bhusari. Its Indian entity Abiogenesis Clinpharm Private Limited reported revenue of ₹13.03 Cr. Abiogenesis Clinpharm offers products and services including Clinical Operations, Data Management, Regulatory Affairs, and Quality Assurance. Its focus areas include Medical Devices, Real World Evidence, Post-Market Surveillance and Clinical Research.
Company details
Abiogenesis Clinpharm, headquartered in Hyderabad, India, operates in Southeast Asia and beyond, supporting pharmaceutical and biotechnology companies with clinical trial services including operations, data management, and regulatory affairs. They handle studies in oncology, endocrinology, and medical devices, ensuring compliance and efficient execution through expert teams and networks. This focus advances healthcare by delivering reliable research outcomes.
- Headquarters Hyderabad, India
- Employees 28
- Founders Pawan Bhusari
- SectorsHealthcare
- Website abiogenesisclinpharm.com
- Social LinkedIn X
- Legal Name Abiogenesis Clinpharm Private Limited
- Date of Incorporation 21 Nov, 2014
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹13.03 Cr
FY 2024 · +114% YoY
- Net Profit₹78.8 Lakh
FY 2024 · 6% margin
- EBITDA₹1.26 Cr
FY 2024 · 10% margin
- Employee Count28
Associated legal entities of Abiogenesis Clinpharm
Abiogenesis Clinpharm operates through Abiogenesis Clinpharm Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Abiogenesis Clinpharm Private Limited CIN U74930TG2014PTC096506 | Active | 21 Nov 2014 | Hyderabad, Telangana | ₹13.0 Cr | 28 | 3 | View details |
Products & Services of Abiogenesis Clinpharm
Abiogenesis Clinpharm offers a comprehensive portfolio of products and services, including Clinical Operations, Data Management, Regulatory Affairs, and Quality Assurance.
Manages execution of clinical trials across therapeutic areas
Ensures accurate and compliant clinical trial data collection
Handles regulatory applications and approvals for trials
Provides quality checks for clinical research projects
Board of directors of Abiogenesis Clinpharm Private Limited (Abiogenesis Clinpharm)
Abiogenesis Clinpharm Private Limited is the primary company behind Abiogenesis Clinpharm. The board of Abiogenesis Clinpharm Private Limited currently have 3 directors; the longest-serving is Pawan Ishwarrao Bhusari, appointed in 2014. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pawan Ishwarrao Bhusari DIN 06989844 | Director | 21 Nov 2014 | 11 yrs 11 mo | Abiogenesis Clinpharm Private Limited |
| Abraham Chikku Joseph DIN 08523909 | Director | 26 Jul 2019 | 7 yrs 3 mo | Abiogenesis Clinpharm Private Limited |
| Kalpesh Kumar Prabhudas Saglani DIN 11365656 | Additional Director | 03 Nov 2025 | 11 mo | Abiogenesis Clinpharm Private Limited |
People of Abiogenesis Clinpharm
1 people are tracked at Abiogenesis Clinpharm (1 in leadership); the tracked headcount is 28.
| Name | Role | Group |
|---|---|---|
| Co-Founder, CEO | Leadership |
Complete people profiles for Abiogenesis Clinpharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Abiogenesis Clinpharm
Figures of Abiogenesis Clinpharm Private Limited, the primary company behind Abiogenesis Clinpharm, for FY 2024. Revenue was ₹13.03 Cr (+114% year on year). Net profit was ₹78.8 Lakh (6% margin). EBITDA was ₹1.26 Cr (10% margin). Revenue has grown at a compounded annual rate of +30% over three years and +40% over five years.
- ₹13.03 CrRevenue · FY 2024 · +114% YoY
- ₹78.8 LakhNet profit · 6% margin
- ₹1.26 CrEBITDA · 10% margin
- ₹1.25 CrPaid-up capital
- 28Employees (provident fund records)
- +30%Revenue CAGR, 3 years
- +40%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Abiogenesis Clinpharm Private Limited are on its company page.
Detailed financial statements for Abiogenesis Clinpharm
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Abiogenesis Clinpharm
The website of Abiogenesis Clinpharm (abiogenesisclinpharm.com) receives about 6K visits a month.
- Monthly visits6K
▲ 624.4% vs previous month
Websites whose visitors overlap most with Abiogenesis Clinpharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| monitrahealth.com | 95% | 1.8K | #8,311,818 | View details | |
| anion.com | 93% | 2.2K | #7,606,830 | View details | |
| primeramed.com | 76% | 11.5K | #2,868,372 | View details | |
| avontix.com | 28% | 1.7K | #8,687,470 | View details | |
| sandor.co.in | 25% | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Abiogenesis Clinpharm
Abiogenesis Clinpharm was founded in 2014.
Abiogenesis Clinpharm is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Pawan Bhusari is the CEO of Abiogenesis Clinpharm, as recorded in our data. They have also founded this company.
Abiogenesis Clinpharm has 28 employees.
The primary company behind Abiogenesis Clinpharm, Abiogenesis Clinpharm Private Limited, reported revenue of ₹13.03 Cr for FY 2024, up 114% year on year.
Abiogenesis Clinpharm, headquartered in Hyderabad, India, operates in Southeast Asia and beyond, supporting pharmaceutical and biotechnology companies with clinical trial services including operations, data management, and regulatory affairs. They handle studies in oncology, endocrinology, and medical devices, ensuring compliance and efficient execution through expert teams and networks. This focus advances healthcare by delivering reliable research outcomes.
Abiogenesis Clinpharm offers Clinical Operations, Data Management, Regulatory Affairs, and Quality Assurance.
Abiogenesis Clinpharm operates through Abiogenesis Clinpharm Private Limited.
The legal entities of Abiogenesis Clinpharm currently have 3 directors, including Abraham Chikku Joseph, Pawan Ishwarrao Bhusari, Kalpesh Kumar Prabhudas Saglani.